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Abstract
Background: Maximisation of the potential of sentinel lymph node biopsy as a minimally invasive
method of axillary staging requires sensitive intraoperative pathological analysis so that rates of re-
operation for lymphatic metastases are minimised. The aim of this study was to describe the test
parameters of the frozen section evaluation of sentinel node biopsy for breast cancer compared to
the gold standard of standard permanent pathological evaluation at our institution.
Methods: The accuracy of intraoperative frozen section (FS) of sentinel nodes was determined in
94 consecutive women undergoing surgery for clinically node negative, invasive breast cancer
(37:T1 disease; 43:T2; 14:T3). Definitive evidence of lymphatic spread on FS indicated immediate
level II axillary clearance while sentinel node "negativity" on intraoperative testing led to the
operation being curtailed to allow formal H&E analysis of the remaining sentinel nodal tissue.
Results:  Intraoperative FS correctly predicted axillary involvement in 23/30 patients with
lymphatic metastases (76% sensitivity rate) permitting definitive surgery to be completed at the
index operation in 87 women (93%) overall. All SN found involved on FS were confirmed as
harbouring tumour cells on subsequent formal specimen examination (100% specificity and positive
predictive value) with 16 patients having additional non-sentinel nodes found also to contain
tumour. Negative Predictive Values were highest in women with T1 tumours (97%) and lessened
with more local advancement of disease (T2 rates: 86%; T3: 75%). Of those with falsely negative
FS, three had only micrometastatic disease.
Conclusion: Intraoperative FS reliably evaluates the status of the sentinel node allowing most
women complete their surgery in a single stage. Thus SN can be offered with increased confidence
to those less likely to have negative axillae hence expanding the population of potential
beneficiaries.
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Background
Sentinel lymph node (SLN) biopsy is now established as
an accurate, minimally invasive means of providing
regional staging for primary breast cancer. As axillary
clearance remains the standard of care for those with
nodal spread[1], many centres however confine the use of
SLN mapping to women with "early" or "small" breast can-
cer (i.e. T1 cancers in most instances)[2]. However, such a
strategy deprives the benefits of minimally invasive lym-
phatic staging from those women who have disease that is
locally advanced but still contained within the breast. Fur-
thermore, means of preoperative T-staging are all too
often inaccurate[3]. Any uncertainty surrounding the
"completeness" of the initial surgery may weigh heavily
on the minds of women undergoing lymphatic mapping
due to the interval between operation and histological
reporting.
An intraoperative means of cytopathological evaluation
of sentinel nodes therefore has clear potential advantages
although concerns over the potential for inconsistencies
of conclusion between the rapid analysis and the formal
paraffin section remain widespread. In this study, we
describe our experience of routine intraoperative frozen
section of sentinel nodes in women with invasive breast
cancer but without overt lymphatic metastases in order to
contribute to the emerging body of data regarding its prac-
tical reliability and clinical utility.
Patients and Methods
The study protocol was reviewed fully and passed by the
local hospital ethics committee.
Patients and surgical technique
Consecutive, consenting, clinically node negative women
with unifocal, invasive breast cancer undergoing surgical
treatment for invasive breast cancer between December
2004 and December 2006 were studied. All patients
underwent synchronous excision of the primary breast
cancer (either by wide local excision or mastectomy) and
sentinel node biopsy by one of two consultant surgeons
(TC or RGW). All women were counselled and fully con-
sented regarding the risk of requiring formal axillary clear-
ance if their sentinel node was found to contain
metastases either on frozen section examination or on
subsequent conventional analysis. The degree of risk com-
municated was dependent mostly on the patient's tumour
size (no patient had palpable lymphadenopathy). Under
the study protocol, any evidence of nodal metastases in
the sentinel node (either by frozen section or on subse-
quent formal pathological examination, including
micrometastases (i.e. deposits <2 mm in diameter), were
taken to mandate subsequent full axillary clearance at a
second operation. This was decided, despite the recent
WHO classification of isolated tumour cells as conferring
a node-negative status, because of both the experimental
nature of the technique in our hands and the ongoing
controversy of whether such cells actually are prognosti-
cally important[4].
Our method of sentinel node identification incorporates
the preoperative injection of both radioisotope and blue
dye as previously described[5]. In brief, radioisotope
tracer (99m-Tc-labelled colloidal rhenium sulphide-
Nanocis, Cis Biointernational) was injected subcutane-
ously peri-tumourly one day prior to surgery. In cases of
an impalpable tumour, fine wire localization (FWL) in
combination with radio-isotope occult lesion localization
(ROLL) methods was implemented[6]. Immediately pre-
operatively, after induction of general anesthesia, 3–5 mls
of isosulphan blue dye (lymphazurin®, Ben Venue Labora-
tories Inc., Bedford OH) was also injected peritumorally.
The SLN was then identified intra-operatively by visual
inspection for blue dye in combination with searching for
radiation counts with a hand held gamma-ray detection
probe (Neoprobe®, Neoprobe Corporation). While the
nodal tissue was being processed by frozen section (see
below), the primary tumour was resected. The excised
breast specimens were examined as usual to ascribe the
type and grade (Bloom Richardson grading of hematoxy-
lin and eosin-stained specimens) of the invasive compo-
nent of the primary tumor, as well as its estrogen (ER) and
progesterone receptor (PR) status.
Pathological examination of the SLN
The same consultant pathologist (RL) examined all the
specimens. Once localized and excised, the SLN(s) was
sent immediately to the laboratory for frozen section
examination. On average, this involved examination of
three sections per node were (using OCT compound and
freezing spray) unless obvious macroscopic metastases
were apparent on the first slice examined. Patients found
to have tumour cells in their SLN biopsy on frozen section
analysis underwent immediate level II axillary lymph
node dissection with all resected tissue being sent for
standard pathological processing and review. Any remain-
ing sentinel nodal tissue after frozen sectioning were fixed
in formalin and embedded in paraffin with subsequent
examination by H&E staining (again an average of 3 levels
per node with a fixed distance between levels of 100
microns.) and, if any uncertainty pertained, immunohis-
tochemistry. With regard to the nodes excised as part of an
axillary clearance, smaller nodes were bisected and the
whole node examined as per the sentinel node. Larger
nodes were bisected and one half examined similarly. If
no macroscopic metastases were evident, the other half
was then also examined.World Journal of Surgical Oncology 2008, 6:69 http://www.wjso.com/content/6/1/69
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Results and Statistical analysis
The results of the immediate, intraoperative FS assessment
of the SLN were then compared with that of their delayed
formal pathological examination with regard to nodal
oncological status. ANOVA testing was used to examine
for statistically significant differences between the groups
with the Bonferroni correction used post hoc because of
small numbers involved.
Results
Patient demographics and tumor characteristics
In total, 94 women were included in the study. Their
mean age was 60 years (range 35–81, 73 being older than
50). Twenty eight patients had breast-conserving surgery
(two required radiological guidance to localise the pri-
mary) while the remainder underwent mastectomy due
either to high tumor:breast size, central location of the
tumour or the patient's own preference. On final patho-
logical analysis of the resected primary, 37 patients were
found to have T1 tumours (2 were T1a, 9 were T1b and 26
were T1c) while 43 were T2 and 14 T3. Seventy six cancers
were ductal adenocarcinoma while 18 were lobular in
type. Nine were Grade I by Bloom Richardson scoring on
H&E examintion while 50 were Grade II and 35 Grade III.
Seventy eight of cancers were ER positive with 12 being
both ER and PR positive.
Sentinel Node Identification and frozen section analysis
There were no failed lymphatic mappings. The median
number of SLN identified was 2 (mean 2.1 range 1–6).
Intraoperative frozen section of the sentinel nodes identi-
fied tumour cells in 23 women with the subsequent for-
mal H&E examination confirming the presence of
lymphatic metastases in every one. Each of these patients
underwent immediate level II axillary clearance on receipt
of the frozen section report. The mean number of nodes
subsequently harvested at axillary clearance was 15.3
(range 3–39). Sixteen patients had further nodal metas-
tases identified in their non-sentinel nodes.
Formal sentinel node analysis
Formal pathological examination identified nodal
tumour deposits in seven patients whom the initial frozen
section deemed not to have lymphatic dissemination. The
frequency of false negative cases among those judged to
be negative by frozen section analysis was therefore 9.9%
while the false negative rate was 23%. Three of these
patients actually had micrometastatic disease in their sen-
tinel node (one of these patients required further immu-
nohistochemical staining to confirm the presence of
malignant cells on the formal specimen). All patients with
involved nodes underwent level II axillary clearance at a
second operation as per protocol. The mean number of
nodes cleared at this operation was 11.5 (range 6–22). In
two patients the sentinel node(s) were the only involved
nodes while the other five women (included two of whom
had only micrometastases evident in their sentinel node)
had non-sentinel nodal metastases evident on full exami-
nation of the residual lymphatic basin.
Comparison of frozen section analysis with formal 
pathological examination
The sensitivity and specificity rates as well as positive and
negative predictive values both overall and by final path-
ological T stage are shown in Table 1. The accuracy of fro-
zen section analysis of sentinel nodes according to
Table 1: Relationship between intraoperative frozen section (FS) of sentinel lymph nodes (SLN) and formal final histological analysis 
available after surgery.
Relationship between sentinel nodal analysis by Frozen Section and Conventional Histology
Paraffin section
Crude data Status Positive Negative Total
Frozen Section Positive 23 0 23
Negative 7 64 71
Total 30 64 94
Utility of intraoperative FS Overall T-stage
Parameter %T 1 T 2 T 3
Sensitivity 76 91% 69% 66%
Specificity 100% 100% 100% 100%
Positive Predictive Value 100% 100% 100% 100%
Negative predictive value 90% 97% 86% 75%World Journal of Surgical Oncology 2008, 6:69 http://www.wjso.com/content/6/1/69
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tumour size was 97% for T1 tumours, 91% for T2 tumours
and 86% for those with T3 disease. For those with Grade
III cancers, it was 91%. The characteristics of those
patients with false negative frozen sections in contrast to
those with true negative and true positive frozen section
results are shown in Table 2. As is evident from the table,
patients with false negative sentinel node analysis by fro-
zen section tended to have less sentinel nodes resected.
They were also more likely to have larger tumours that
were ER negative and were less likely to have Grade I
tumours. On formal statistical analysis, however, no sig-
nificant difference was demonstrable between the groups.
Discussion
The Role of SLN Biopsy
While there remains some dispute on the role of routine
axillary clearance in selected patients with lymphatic
metastases, most authorities recommend lymph basin
dissection for node positive women in order to both fully
debulk and stage the disease. Therefore, women found to
have axillary disease after conventional pathological
examination of their SLN require a second, separate oper-
ation to clear their (now scarred) axilla. A high likelihood
of nodal disease undermines confidence in the potential
advantages of SLN biopsy as any benefits to be derived
from this technique are quickly outweighed by the physi-
cal risks and psychological detriment of a second reopera-
tive procedure. Therefore many proponents of lymphatic
mapping advocate that the technique be only imple-
mented in patients with "early" breast cancer (that is,
those with T1 cancers and a clinically negative axilla).
Recent reports however have shown that the technique
can function reliably in more advanced T-stages[7,8]
although clearly such patients have a higher risk of nodal
metastases and therefore a greater risk of needing a second
operation if convention histological examination of the
nodes is employed[9].
Pitfalls of Preoperative Selection of Patients for SLN 
Biopsy
The ability to precisely measure tumours before their
resection is however limited and clinical examination of
the axilla is itself known to lack sufficient specificity and
sensitivity to confidently guide appropriate patient selec-
tion for this technique[10]. How best preoperatively avail-
able measures of the primary tumor characteristics[11]
can be used to select patients for SLN prior to definitive
surgery is also unclear[12,13]. Furthermore, as selection
criteria become increasingly stringent, a diminishing pro-
portion of patients who could benefit from sentinel node
biopsy are selected for the technique[5]. Additionally, it is
uncertain whether recommendations based on T-stage
alone can even be applied to symptomatic patients.
Intraoperative SLN Analysis by Frozen Section 
Examination
An accurate means of intra-operative analysis of sentinel
nodes has the potential to allow the completion of surgi-
cal treatment for a patient with breast cancer in a single
session. While touch imprint cytology has been suggested
as being a useful means of such analysis[14,15], currently,
it is limited by its availability as well as variable sensitivity
rates and, perhaps, most worryingly specificity rates that
are less than 100% (therefore still risking a chance of con-
demning women without nodal disease to axillary clear-
ance). Data on frozen section assessment however is
emerging showing sufficient[16,17], and perhaps supe-
rior[18], intraoperative evaluation of nodal tumour bur-
den, despite initial concerns that it consumes more of the
specimen than cytological assessment. Analysis of pub-
lished data to date shows that the accuracy of frozen sec-
tion analysis with a combination of H&E staining and
immunohistochemistry on sentinel lymph nodes lie
between 73 to 96% [19-30].
Discussion of Experience Presented in This Study
Overall the use of intraoperative frozen section analysis of
sentinel node allowed 87/94 patients to have the axillary
component of their surgery completed in a single step.
Patients could also be informed of their status with this
degree of confidence on awaking from anaesthesia. As has
been suggested previously[24], the facility for intraopera-
tive analysis of sentinel node status was particularly
advantageous for those with larger tumors. Furthermore,
the accurate, intraoperative selection of 23 of the 30
patients with axillary metastases allowed definitive axil-
lary operation to be concluded at the index operation with
confidence of therapeutic benefit. A second operation rate
Table 2: Characteristics of patients by the frozen section status of the sentinel lymph nodes (SLN) found at the time of definitive 
surgery for the invasive primary.
SLN Category Age SLN No. T size Tumour Grade ER and PR staining
Mean (yrs) Mean T1 T2 T3 I II III ER positive ER & PR positive ER & PR negative
True Negative SLN by FS (n = 64) 61.5 2.02 34 24 6 8 33 22 53 39 8
True Positive SN by FS (n = 23) 62.8 2.1 10 9 4 0 10 13 21 19 2
Total True SN by FS (n = 87) 62.2 2.1 44 33 10 8 43 35 74 58 10
False Negative SN by FS (n = 7) 57.9 1.9 1 4 2 0 4 3 4 3 2World Journal of Surgical Oncology 2008, 6:69 http://www.wjso.com/content/6/1/69
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of 7% overall (23% in node positive patients) seems jus-
tifiable in the light of being able to maximize the numbers
of node-negative women who can and should benefit
from SLN. Rather than 45 T1 patients undergoing this
procedure with five requiring a second operation for
unexpected lymphatic disease, incorporation of frozen
section analysis allowed all seventy one node-negative
women in this series the benefits of minimally invasive
determination of lymph node status at the expense of
seven second procedures. The major undermining factor
for frozen section analysis was in the detection of
micrometastatic disease. While much attention is cur-
rently being focussed on micrometastatic detection in sen-
tinel nodes, the clinical and prognostic significance of the
finding of just a few malignant cells has not yet been fully
elucidated.
Conclusion
FS is again shown here to be a reliable method for evalu-
ation of sentinel lymph nodes in patients with breast can-
cer. It allows immediate decision making regarding the
need for ALND in the majority of patients.
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